Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.62% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
CPI Card Group
PMTS
$334M
| $217K | ﹤0.01% |
+7,792
| New | +$214K |
|
|
VLRS
3102
Controladora Vuela Compania de Aviacion
VLRS
$922M
| $216K | ﹤0.01% |
34,200
-500
| -1% | -$3.05K |
|
|
GHSI
3103
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
| $215K | ﹤0.01% |
38,804
+1,884
| +5% | +$19.1K |
|
|
NUTX
3104
Nutex Health
NUTX
$1.28B
| $215K | ﹤0.01% |
9,898
+4,208
| +74% | +$60.7K |
|
3105
Verrica Pharmaceuticals
VRCA
$83.5M
| $215K | ﹤0.01% |
14,796
+10,243
| +225% | +$461K |
|
|
MOFG
3106
DELISTED
MidWestOne Financial Group
MOFG
| $211K | ﹤0.01% |
7,400
-3,600
| -33% | -$97.7K |
|
3107
iShares Expanded Tech Sector ETF
IGM
$10.9B
| $211K | ﹤0.01% |
+2,200
| New | +$203K |
|
|
EBTC
3108
DELISTED
Enterprise Bancorp
EBTC
| $211K | ﹤0.01% |
6,600
-11,948
| -64% | -$343K |
|
3109
IZEA Worldwide
IZEA
$53.8M
| $211K | ﹤0.01% |
76,703
+1,100
| +1% | +$2.57K |
|
3110
Advanced Energy
AEIS
$13.2B
| $210K | ﹤0.01% |
1,996
-9,626
| -83% | -$1.01M |
|
3111
Xilio Therapeutics
XLO
$59.3M
| $210K | ﹤0.01% |
19,021
-2,050
| -10% | -$25.2K |
|
3112
Avalon Holdings
AWX
$10.9M
| $209K | ﹤0.01% |
82,010
-100
| -0.1% | -$240 |
|
3113
Dare Bioscience
DARE
$20.5M
| $209K | ﹤0.01% |
64,395
-497
| -0.8% | -$1.7K |
|
3114
SIFCO Industries
SIF
$121M
| $208K | ﹤0.01% |
44,834
-700
| -2% | -$2.76K |
|
3115
Fortrea Holdings
FTRE
$1.69B
| $208K | ﹤0.01% |
10,400
-285,200
| -96% | -$6.7M |
|
|
SYRS
3116
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $207K | ﹤0.01% |
96,435
-21,000
| -18% | -$75.4K |
|
|
BERY
3117
DELISTED
Berry Global Group, Inc.
BERY
| $206K | ﹤0.01% |
3,307
-88,754
| -96% | -$5.27M |
|
3118
Vince Holding Corp
VNCE
$78.9M
| $206K | ﹤0.01% |
111,550
-2,900
| -3% | -$4.8K |
|
3119
American Shared Hospital Services
AMS
$10.6M
| $206K | ﹤0.01% |
67,449
+11,948
| +22% | +$37K |
|
3120
Treace Medical Concepts
TMCI
$293M
| $205K | ﹤0.01% |
35,300
-171,200
| -83% | -$1.1M |
|
3121
GH Research
GHRS
$1.94B
| $203K | ﹤0.01% |
30,400
| – | – |
|
|
CARM
3122
DELISTED
Carisma Therapeutics
CARM
| $203K | ﹤0.01% |
206,757
+67,397
| +48% | +$73K |
|
|
CTHR
3123
DELISTED
Charles & Colvard Ltd
CTHR
| $203K | ﹤0.01% |
117,269
-1,800
| -2% | -$3.15K |
|
|
GOCO
3124
DELISTED
GoHealth
GOCO
| $202K | ﹤0.01% |
21,572
+3,300
| +18% | +$33.4K |
|
|
LONA
3125
LeonaBio Inc
LONA
$73.9M
| $202K | ﹤0.01% |
45,279
+18,130
| +67% | +$425K |
|
Similar funds
Jim Simons's Q3 2024 Portfolio in Review
As of Q3 2024, Jim Simons held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Jim Simons's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Jim Simons added most to Microsoft in Q3 2024, an estimated $533M increase.
- Jim Simons's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Jim Simons fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Jim Simons's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Jim Simons opened 578 new positions and closed 539 in Q3 2024.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.